The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
Antibody responses have not been fully characterised in chronically HIV/HCV patients receiving antiretroviral therapy (ART). Seventeen HIV/HCV patients receiving ART were followed for a median (range) interval of 597 (186–766) weeks. Prior to ART, HIV/HCV patients had lower levels of antibodies reac...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Academic Press
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/54437 |